Package 0832-7123-01

{"route": ["ORAL"], "spl_id": "45afcbe0-c2e7-008a-e063-6394a90a111e", "openfda": {"unii": ["644VL95AO6"], "rxcui": ["1099625", "1099678", "1099870"], "spl_set_id": ["02304a23-4a5f-47bc-9687-4044b43f7a20"], "manufacturer_name": ["Upsher-Smith Laboratories, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 BLISTER PACK in 1 CARTON (0832-7123-01)  / 1 TABLET, DELAYED RELEASE in 1 BLISTER PACK (0832-7123-89)", "package_ndc": "0832-7123-01", "marketing_end_date": "20270831", "marketing_start_date": "20160401"}, {"sample": false, "description": "100 TABLET, DELAYED RELEASE in 1 BOTTLE (0832-7123-11)", "package_ndc": "0832-7123-11", "marketing_end_date": "20270831", "marketing_start_date": "20140321"}, {"sample": false, "description": "500 TABLET, DELAYED RELEASE in 1 BOTTLE (0832-7123-15)", "package_ndc": "0832-7123-15", "marketing_end_date": "20270623", "marketing_start_date": "20140321"}], "brand_name": "Divalproex Sodium", "product_id": "0832-7123_45afcbe0-c2e7-008a-e063-6394a90a111e", "dosage_form": "TABLET, DELAYED RELEASE", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Mood Stabilizer [EPC]"], "product_ndc": "0832-7123", "generic_name": "Divalproex Sodium", "labeler_name": "Upsher-Smith Laboratories, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Divalproex Sodium", "active_ingredients": [{"name": "DIVALPROEX SODIUM", "strength": "250 mg/1"}], "application_number": "ANDA078182", "marketing_category": "ANDA", "marketing_end_date": "20271031", "marketing_start_date": "20140321"}